Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs Incannex Healthcare Inc. (IXHL)

Citius Oncology, Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $46.5M against $28.5M — 1.6× the size. Across the 10 metrics below, Incannex Healthcare Inc. leads on 9 and Citius Oncology, Inc. on 1.

Valuation

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 16.88 2.08
P/B 1.36 0.39 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 1.65 12.22
EV/Sales n/m (24.08) 2.87
Earnings yield (92.16%) (75.75%) (15.94%)
Free cash flow yield (58.41%) (48.87%) 0.00%

Profitability

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
Gross margin — (0.10%) 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (126.58%) (47.80%) (0.80%)
Return on assets (45.20%) (41.32%) (1.67%)
Return on invested capital (67.15%) 0.00% 0.00%

Growth

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) (9.68%) 95.91% 42.91%
Revenue growth, 5-year CAGR — (29.64%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.04
Current ratio 0.73 48.81 2.41
Net debt to EBITDA (0.40) 2.97 1.01

Dividend

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CTOR IXHL Drug Manufacturers Specialty & Generic median
Market cap 46.50m 28.47m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack